LITTLE ROCK, Ark. —The University of Arkansas for Medical Sciences will offer a third dose of the COVID-19 vaccine to its moderately and severely immunocompromised patients beginning on Monday, Aug. 16.
Appointments are required.
Under guidelines issued by the Federal Drug Administration, only patients who received the two-shot Pfizer or Moderna vaccines and who meet the definition of moderately or severely immunocompromised are eligible for a third dose. The third dose should be the same vaccine the patient received earlier.
UAMS patients eligible for a COVID booster include:
- Those in active treatment for solid tumor and hematologic malignancies
- Transplant patients who are taking immunosuppressive therapy
- Those who have received CAR-T cell therapy or a stem cell transplant (within two years of transplantation or still taking immunosuppressive therapy)
- Those with advanced or untreated HIV infection
- Those undergoing active treatment with high-dose corticosteroids and other pharmaceuticals that are immunosuppressive or immunomodulatory
Existing UAMS patients should contact their physician to see if they are eligible for a booster and to schedule an appointment.